Drug Database
SA

salbutamol + ipratropium bromide (Respimat Combivent)

✓ Approved

Boehringer Ingelheim International GmbH · ADRB2 · 小分子

什么是 salbutamol + ipratropium bromide?

salbutamol + ipratropium bromide 是一种小分子,由Boehringer Ingelheim International GmbH研发。该药已获批,用于治疗相关适应症,给药途径:Inhaled。

药物档案

商品名Respimat Combivent
公司Boehringer Ingelheim International GmbH
药物类别小分子
分子靶点ADRB2, CHRM1, CHRM2, CHRM3, CHRM4
给药途径Inhaled
状态Approved

作用机制

分子靶点

salbutamol + ipratropium bromide 作用于 5 个分子靶点:

ADRB2adrenoceptor beta 2 (B2AR, ARB2)
CHRM1cholinergic receptor muscarinic 1 (M1, HM1)
CHRM2cholinergic receptor muscarinic 2 (HM2)
CHRM3cholinergic receptor muscarinic 3 (HM3, PBS)
CHRM4cholinergic receptor muscarinic 4 (HM4, M4R)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

salbutamol + ipratropium bromide 针对 2 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Respiratory, thoracic and mediastinal disordersChronic obstructive pulmonary disease✓ Approved
Respiratory, thoracic and mediastinal disordersAsthmaPhase III

相关研究文献

PubMedPhotochemistry and photobiology2026-11-19

Influence of ligand charge and pi-expansion on DNA binding ability of protic ruthenium complexes with light-activated anticancer activity.

Kuehner Elena C EC, Khweis Sarah A SA, Petersen Courtney M CM, Patel Ish I et al.

Photoactivated Ru(II) polypyridyl complexes containing diprotic ligands and extended π systems have been synthesized and investigated as anticancer agents in cell studies. The DNA binding properties of the photoactivated ruthenium complexes [(bphen)2Ru(4,4'-dhbp)]Cl2 (1A), [(dppz)2Ru(4,4'-dhbp)]Cl2 (2A), [(bphen)2Ru(4,7-dhphen)]Cl2 (3A), and [(dppz)2Ru(4,7-dhphen)]Cl2 (4A) were investigated to further characterize these compounds and their mode of action (where bphen = bathophenanthroline, dppz = dipyrido[3,2-a:2',3'-c]phenazine, 4,4'-dhbp = 4,4'-dihydroxy-2,2'-bipyridine, and 4,7-dhphen = 4,7-dihydroxy-1,10-phenanthroline). Initial studies probed the DNA binding ability of these compounds by circular dichroism and UV-Visible spectroscopy, and these methods were suggestive of DNA binding but not quantitative. DNA binding was further investigated by fluorescence emission quenching in a competitive binding assay, with each Ru complex displacing ethidium bromide. Ru compounds were evaluated relative to the weak DNA binder [Ru(bpy)3]Cl2 (Lit-1) and the known DNA intercalator [(phen)2Ru(dppz)]Cl2 (Lit-2). Stern-Volmer quenching constants and competitive binding constants were determined for each compound. Trends in binding affinity indicate the role of pH-sensitive ligand charge in binding DNA, providing further insight into the structure-activity relationship of these compounds.

PMID 43053657
阅读全文 →
PubMedBiological & pharmaceutical bulletin2026-11-18

Berberine Derivatives as Potent Inhibitors of Adipocyte Differentiation and Lipid Accumulation in 3T3-L1 Cells.

Nobushi Yasuhito Y, Wada Taira T, Saito Hiroaki H, Aoyama Takahiko T et al.

Berberine is a quaternary benzylisoquinoline alkaloid found in various medicinal plants, including species of Coptis, Phellodendron, and Berberis. Berberine exerts anti-inflammatory effects and lowers blood glucose, cholesterol, and triglyceride levels, suggesting its potential for preventing lifestyle-related diseases. This study investigated the effects of 23 berberine derivatives on adipocyte differentiation and lipid accumulation in 3T3-L1 cells. At 1 μM, several berberine derivatives markedly inhibited lipid accumulation during adipocyte differentiation without affecting cell viability, and seven of these derivatives demonstrated inhibitory activity comparable to that observed with 4 μM berberine. Notably, 13-ethylberberine iodide (1), 13-allylberberine bromide (9), and 8-n-butylberberine bromide (19) exhibited dose-dependent inhibitory effects. These derivatives (1, 9, and 19) significantly suppressed the expression of adipocyte marker genes, including peroxisome proliferator-activated receptor γ2 (Pparγ2), CCAAT/enhancer binding protein α, and adipocyte fatty acid binding protein. Further analysis revealed that these derivatives reduced early differentiation-associated cell proliferation, Pparγ2 expression, and PPARγ2 transcriptional activity. Thus, these derivatives may represent promising candidates for developing agents that modulate adipocyte differentiation and lipid accumulation.

PMID 43051879
阅读全文 →
PubMedCrystal growth & design2026-11-18

Epimer-Dependent Solid-State Landscapes of Trospium and Exotrospium Halide Salts.

Babor Martin M, Spingler Bernhard B, Šimek Josef J, Čejka Jan J et al.

Trospium (TR) and exotrospium (ETR) form a closely related epimeric pair of quaternary ammonium compounds, differing only in the stereochemistry of the tropane ring system. While the solid-state chemistry of trospium has been studied mainly for its chloride salt, no crystal structures of exotrospium salts have previously been reported. Here, we investigate the epimer-dependent solid-state landscapes of TR and ETR across the halide series, using matched salt forms to distinguish the effects of counterion selection from those of stereochemical inversion. Two new TR salts and three new ETR salts were prepared and structurally characterized by single-crystal X-ray diffraction, supported by crystal-packing comparison, hydrogen-bond propensity analysis, lattice-energy calculations, morphology prediction, and CSD-Particle surface analysis. Despite their close molecular similarity, TR and ETR display markedly different solid-state behavior. TR forms anhydrous chloride, bromide, and iodide salts stabilized by direct charge-assisted O-H···halide interactions, whereas ETR forms isostructural chloride and bromide dihydrates, with only the iodide obtained as an anhydrate. These differences are reflected in molecular conformation, crystal packing, hydration behavior, predicted crystal habit, and surface descriptors. The results show that epimerization can substantially alter both bulk and surface features of pharmaceutical molecular salts and demonstrate the value of combining structural comparison with particle-level descriptors when evaluating related solid forms.

PMID 43048678
阅读全文 →
PubMedAnalytical chemistry2026-11-18

Designing of a Test Tube Containing Aptamer-Immobilized Cholesteric Liquid Crystal Network-Based Optical Photonic Sensors for the Multiplex Detection of Doping Substances in Human Blood Serum.

Bashir Manal M, Hussain Saddam S, Cialla-May Dana D, Popp Jürgen J et al.

The detection of doping substances in human serum is a critical concern in both clinical diagnostics and anti-doping efforts. In this study, we present a novel, portable, and cost-effective biosensor system based on cholesteric liquid crystal networks (CLCN) for multiplexed drug detection. The system employs aptamer-immobilized CLCN-based optical sensors, fabricated on flexible polyethylene terephthalate (PET) substrates, for the onsite detection of cocaine, methamphetamine, heroin, tramadol, and salbutamol. The biosensor platform utilizes the unique optical properties of CLCNs, where the helical pitch change in response to analyte binding results in visible color shifts. These sensors are easy to fabricate, as all liquid crystals used are commercially available and inexpensive, making the technology highly accessible. Additionally, the sensors are easy to use, requiring minimal training, and the results can be quickly interpreted via a simple visual readout. The system was evaluated for its performance in spiked human serum samples, demonstrating high sensitivity, specificity, and accuracy in detecting low concentrations of doping substances. The inclusion of QR codes on the sensors allowed for convenient comparison with calibrated reference standards, ensuring reliable results. This biosensor system offers a promising solution for on-site and multiplexed detection of doping substances in human serum, with significant potential for monitoring in clinical and athletic settings.

PMID 43046414
阅读全文 →
PubMedChemMedChem2026-11-18

Synthesis, Structure, and In Vivo Evaluation of Analgesic Activity of N-propargyl-2-methyl-trans-decahydroquinolin-4-one Oximes.

Dubrovskiy Vladislav A VA, Starodubtseva Alena A AA, Shoibek Karina S KS, Sosin Vadim G VG et al.

Two new N-propargyl derivatives of trans-2-methyl-decahydroquinolin-4-one and their corresponding oximes were synthesized from individual trans-epimers via N-alkylation with propargyl bromide followed by oximation. A solvent-minimized mechanochemical protocol enabled rapid conversion of the ketones into the target oximes within 3-5 min and provided isolated yields of about 96%, while a solution-phase control using the same base required 5 h. Single-crystal X-ray diffraction confirmed the structures and stereochemistry of all four compounds and showed that oximation proceeds stereoselectively to give exclusively E-configured products while preserving the trans-fused bicyclic framework. Biological evaluation included an egg albumin denaturation assay, the hot plate test in mice, and acute oral toxicity studies. Both ketones and oximes showed marked protein-stabilizing activity, with no consistent effect of oximation or C2 methyl-group orientation in this assay. All four compounds showed increases in mean nociceptive-response latency at selected time points, while the oximes, particularly those containing an axial methyl group, showed higher mean responses than the corresponding ketones at several early and intermediate time points. Acute oral toxicity studies classified all four compounds as toxicity class IV, with LD50 values of approximately 1048-1295 mg/kg. Thus, oximation retained the low acute-toxicity profile of the N-propargylated ketones while preserving biological activity.

PMID 43046533
阅读全文 →
PubMedAnalytical chemistry2026-11-18

Multiplex Isotope Tagging-Electromembrane Extraction of Metabolites with Diverse Polarities.

Liu Yangyang Y, Chen Li L, Ma Shengtao S, Pedersen-Bjergaard Stig S et al.

In this work, a multiplex isotope tagging-electromembrane extraction (MIT-EME) strategy was proposed to address two critical drawbacks of conventional EME in metabolite analysis: failure to simultaneously extract polar and non-polar metabolites, and limited analytical throughput. Specifically, seven carnitines covering the hydrophobicity (log P) range of -0.5 to 3.2 were selected as model analytes, and were studied in human serum samples. The carnitines were labeled with p-dimethylaminophenacyl (DmPA) bromide and its two isotopic analogues for sample encoding. Labeled samples were then pooled and subjected to EME and liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis. The labeling increased the lipophilicity of the carnitines (0.9 ≤ log P ≤ 4.6), thereby increasing the partition coefficient by more than two orders of magnitude and the transmembrane flux by up to 43.9-fold, ultimately enabling efficient simultaneous extraction of polar and non-polar carnitines with recoveries of 62-95%. The MIT-EME-LC-MS/MS method provided satisfactory limits of detection (0.02-0.09 ng mL-1), accuracy (90-113%), precision (≤14%), and matrix effects (90-107%). Benefiting from isotopic multiplexing, samples were pooled and analyzed in a single LC-MS/MS run, and achieved the synchronous analysis of three serum samples. The method was applied to serum samples from 100 hyperuricemia patients and 200 healthy individuals, and obvious intergroup differences of serum carnitines were observed. The strategy developed in this study provides a powerful approach for large-scale metabolomics analysis.

PMID 43046476
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多salbutamol + ipratropium bromide